At the 124,000-square foot Cambridge headquarters of Mass Innovation Labs, co-founder & CEO Amrit Chaudhuri points to a cluster of tables and identifies them one by one: This startup went public and did a massive deal with Merck (NYSE:MRK), he says, and sits shoulder-to-shoulder with a different company working on a Phase II clinical asset.
More than a dozen startups call Mass Innovation Labs home, with groups working on projects ranging from immunoncology to genomics to medical devices. The organization launched in 2015, with the hope of helping startups by taking on the role of COO.
“Effectively, our concept was there has to be a better way of doing research,” Chaudhuri told Drug Delivery Business News. “Having built companies that do research, it is a cumbersome, capitally expensive and really risky thing to do. And I’m not just even talking about the quality of research you’re doing. Just getting a high-quality place that is the appropriate place to research is really, really hard.”
Get the full story at our sister site, Drug Delivery Business News.
The post Mass Innovation Labs expands to give startups a better way to do research appeared first on MassDevice.